Portfolio Company

Nitinotes

Nitinotes

Nitinotes develops effective and safe minimally invasive solutions for treating obesity

2018

Year invested

Fund I

MTIP Fund

Israel

Location

Active Investment

Investment status

Obesity / Gastroenterology

Segment

Nitinotes

Overview

Nitinotes is engaged in the fight against obesity, one of the fastest-growing conditions in the world. According to the World Health Organization, >1 billion people around the globe suffer from obesity, a largely untreated condition with <1% eligible to Standard of Care and a leading factor for early death. Nitinotes has developed EndoZip, a fully automated and minimally invasive medical device, allowing durable sutures to reduce the stomach size in obese patients for effective weight loss.

Great Ideas. Long-term results.

Investments that
make a difference.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.

Media

Trends and insights
from our health experts.

Contact

You would like to invest
into the next big thing?

As a long-term investor with a track record of creating successful and sustainable businesses, our goal is to deliver attractive strategic and financial returns to our investors.

Bubble